Hemodialysis using heparin-bound Hemophan in patients at risk of bleeding

Nephron Clin Pract. 2004;97(1):c5-10. doi: 10.1159/000077589.

Abstract

Background/aims: Since heparin can bind to Hemophan, hemodialysis using heparin-bound Hemophan (HBH-HD) could be a useful modality in patients at risk of bleeding. We designed a simplified heparin binding technique and assessed the safety and efficiency of HBH-HD.

Methods: To bind heparin to Hemophan, heparin solution (1 liter, 20 IU/ml saline) was recirculated through Hemophan (GFS plus 11, Gambro) for 1 h while the saline solution (700 ml/h) was removed. In 28 maintenance dialysis patients at risk of bleeding, we evaluated the heparin concentration (HC) and activated partial thromboplastin time (aPTT) during HBH-HD to assess the increased risk of bleeding. We compared the safety and efficiency of HBH-HD with that of routine hemodialysis with low-dose heparinization (R-HD) in a prospective cross-over study, and then analyzed the outcomes of 1,057 HBH-HD in 159 patients.

Results: During HBH-HD, there was a slight increase in both HC (0.15 +/- 0.03 IU/ml, p < 0.01) and aPTT (43.7 +/- 5.7 s, p < 0.01) at 15 min after the initiation of dialysis compared to predialysis levels (0.11 +/- 0.03 IU/ml and 37.5 +/- 6.3 s). However, there was no increase in HC and aPTT at 60 min, 120 min and at the end of dialysis. In a cross-over study, aPTT during dialysis was markedly lower in HBH-HD than in R-HD (p < 0.01). The Kt/V (1.22 +/- 0.31, p > 0.05) and urea clearance (136 +/- 17 ml/min, p > 0.05) of HBH-HD did not significantly differ from those of R-HD (1.29 +/- 0.57 and 136 +/- 13 ml/min). However, the loss of total blood compartment volume of the dialyzer was greater in HBH-HD (17.5 +/- 9.2%, p < 0.01) than in R-HD (2.9 +/- 1.2%). Out of 1,057 HBH-HD, 982 HBH-HD (93%) were successfully completed while 75 HBH-HD (7%) resulted in severe clotting.

Conclusion: We conclude that the HBH-HD could minimize the bleeding risk and be an efficient HD technique in patients at high risk of bleeding. Careful observation for extracorporeal clotting is, however, required during HBH-HD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adsorption
  • Adult
  • Aged
  • Anticoagulants / administration & dosage*
  • Anticoagulants / pharmacokinetics
  • Biocompatible Materials*
  • Cellulose* / analogs & derivatives*
  • Cross-Over Studies
  • Female
  • Hemorrhage / prevention & control*
  • Heparin / administration & dosage*
  • Heparin / pharmacokinetics
  • Humans
  • Male
  • Middle Aged
  • Partial Thromboplastin Time
  • Prospective Studies
  • Renal Dialysis / instrumentation
  • Renal Dialysis / methods*

Substances

  • Anticoagulants
  • Biocompatible Materials
  • Hemophan
  • Cellulose
  • Heparin